Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Thionine is a cationic phenothiazine-structured small molecule known for its physicochemical properties. It functions as a common biological dye, particularly useful in histology due to its strong affinity for biological membranes. Additionally, thionine serves as a photosensitizer in phototherapy and photodynamic antimicrobial inactivation. Its phenothiazine pharmacophore contributes to its selectivity against microbial and tumor cells. Research indicates its potential therapeutic application in Alzheimer's disease by modulating tau phosphorylation and affecting amyloid precursor protein metabolism. Thionine also acts as a nonlinear inhibitor of human plasma butyrylcholinesterase. Furthermore, it is widely utilized as a redox-active probe or electron mediator in various electrochemical biosensors and immunosensors for the detection of biomarkers and contaminants.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on thionine.